Tomorrow BioTech and Green2Gold unite to support biotech and green innovators with labs, mentorship, and a path to ...
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...
MARTINSRIED, Germany--(BUSINESS WIRE)--SIRION Biotech GmbH announced today that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST™ for use in their CAR-T cell products. CAR-T cell ...
Hosted on MSN
Is Precigen (PGEN) The Hot Biotech Stock Under $5?
We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Precigen, Inc. (NASDAQ:PGEN) stands against other hot biotech stocks under $5. The ...
O]ur companies have until June of 2028 to get there. That should not be a sigh of relief. That should be a, oh my gosh, we've ...
Hosted on MSN
Biotech Ingredients Are Beauty’s Next Big Thing—Here’s How They’re Changing Skincare as We Know It
When it comes to beauty formulations that are inclusive of people and planet, finding a middle ground is not always easy. Natural ingredients often rely on farming practices that often require a lot ...
Trinity Biotech plc announced a significant step in its transformation plan by appointing Barclays Capital Inc. as its exclusive financial advisor. The company is shifting its focus to developing its ...
Bernhard running samples at the DARO lab at the BioTech Connector on the Nebraska Innovation Campus. Photo provided by DARO. DARO, a biotech startup in Lincoln centered around early disease detection ...
The American Seed Trade Association will be the lead advocate for crop biotechnology now that the Biotechnology Innovation Organization has eliminated its agriculture and environment section. ASTA was ...
In cancer immunotherapy, the question is rarely whether a drug can activate the immune system. The harder question is whether it can do so without activating it everywhere at once. That distinction ...
Regarding market potential, I see it following an exponential curve, with forecasts indicating that by 2030, gene therapies and genetic corrections will become more widely available, potentially ...
The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to breakthrough innovations and increased deals involving NASDAQ biotech stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results